TuesdayDec 08, 2020 2:36 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Stands Distinct Among Many Peers, Public Companies with Debt-Free Status

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, recently announced a corporate update and financial results for the quarter ended Sept. 30, 2020 (https://ibn.fm/CEDLQ). In addition to being debt free, Energy Fuels had working capital of $44.7 million at the end of Q3 2020, which is a 17% increase over Q2 2020. An article discussing Energy Fuels’ ability to achieve a debt-free status quotes the company’s president and CEO Mark S. Chalmers, who stated, “While many uranium and other natural resource companies have significant debt burdens, Energy Fuels is proud to announce…

Continue Reading

TuesdayDec 08, 2020 2:24 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Creates ‘Hybrid’ Model for Virtual Performances Around the World

Friendable (OTC: FDBL), a mobile technology and marketing company that leverages proprietary applications to connect and engage users, has achieved record increases in new artists to its live streaming platform. Fan Pass, the company’s flagship product, provides exclusive content channels, live streaming events, promotional support, fan subscriptions and custom merchandise designs for artists at all levels, assisting them to build new revenue streams. “As the uncertainty continues around live venues and performances, we feel even stronger demand from artists seeking the foundational elements of performing from the virtual stage,” said Friendable CEO Robert A. Rositano Jr. “No matter how the…

Continue Reading

TuesdayDec 08, 2020 2:14 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Launch of Trxade Prime Purchasing Solution

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company's Integra Pharma Solutions subsidiary. According to the update, Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. The solution allows Trxade platform independent pharmacy members to process, consolidate and ship purchase orders placed directly with Trxade Suppliers via the Trxade Prime service. “The mission of Trxade, from its inception, has been to empower and encourage growth within the independent pharmacy community,” said Trxade Group CEO…

Continue Reading

TuesdayDec 08, 2020 2:14 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Shines Spotlight on Clinical Design for Upcoming Phase 2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, is advancing a drug candidate it hopes will beat the deadly brain cancer Glioblastoma Multiforme (“GBM”). The company recently announced that its submission of an Investigational New Drug (“IND”) application to the U.S. Food & Drug Administration (“FDA”) has been accepted for review and discussed a novel clinical design for its upcoming Phase 2 U.S. trial in a webinar open to the public. “I would like to remind everyone that this upcoming Phase 2…

Continue Reading

TuesdayDec 08, 2020 1:57 pm

QualityStocksNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Solution Shaves Time, Money to Optimize Therapeutic Formulations

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Through its subsidiary Soluble Biotech, the company delivers a solution that reduces the cost, time and manpower needed to optimize therapeutic formulations. A recent article discussing this reads, “HSC Technology is a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients commonly included in protein formulations (https://ibn.fm/QPo4W). The data generated from these screens is analyzed by a predictive algorithm used to identify the optimal combination of additives and excipients, resulting in increased…

Continue Reading

TuesdayDec 08, 2020 1:45 pm

QualityStocksNewsBreaks – HempFusion Wellness Inc. Building Presence in Budding Marketplace

HempFusion Wellness, a leader in the health and wellness cannabidiol (“CBD”) industry, is making strategic moves in a sector that seems to have transcended the upheaval that has defined 2020. The recent U.S. election demonstrated the lasting potential of the market for cannabis-derived products when five states joined the march toward legalizing marijuana for recreational or medicinal uses (https://ibn.fm/6r82d). An article discussing the company reads, “Denver-based HempFusion Wellness has continued to build its own movement toward market success in the cannabis wellness industry, developing 46 products that are currently on shelves while establishing the second-largest cash position in its sector…

Continue Reading

TuesdayDec 08, 2020 12:52 pm

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Impressive Study Results for Fuel4Thought(TM) Brain Booster

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary, Ultimate Brain Nutrients(TM), ( “UBN” ) has released its study of Fuel4Thought(TM) Brain Booster (“F4T(TM)”). According to the update, the study demonstrates impressive results in brain activation, sports vision, hand-to-eye coordination and auditory reaction time. “Fuel4Thought(TM) is one of the main reasons we acquired Ultimate Brain Nutrients(TM),” said GRCK President Duke Pitts. “F4T(TM) Brain Booster is the first of three amazing products we will be…

Continue Reading

TuesdayDec 08, 2020 12:03 pm

QualityStocksNewsBreaks – Gage Cannabis Co. Executive Chairman Discusses Milestones, Record-Breaking Sales, Near-Term Goals in Audio Interview

Gage Cannabis Co., a leading vertically integrated operator in the cannabis industry, today announced that its Executive Chairman Bruce Linton was featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company and one of 50+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Linton provided an update on the company’s recent milestones, its record-breaking cannabis sales in Michigan, as well as its near-term goals that include an IPO planned for 2021. “We found that Michigan is doing more than $100 million a month in cannabis, so the medical and recreational opportunity is there to…

Continue Reading

TuesdayDec 08, 2020 11:40 am

QualityStocksNewsBreaks – Creatd Inc.’s (NASDAQ: CRTD) Platform Crosses 10K Vocal+ Paid Subscribers

Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary creator platform, today announced that it has converted its 10,000th freemium creator to a paid Vocal+ subscriber, a milestone achieved several weeks ahead of management's year-end target. According to the update, Creatd has expanded its Vocal+ premium subscriber base by over 33% in the last three weeks alone, while experiencing record low subscriber acquisition costs. “With the Vocal platform having crossed 10,000 Vocal+ paid subscribers, coupled with a more focused, more accountable sales strategy, I am enthusiastic about our ability to increase our average contract price as well as the…

Continue Reading

TuesdayDec 08, 2020 11:15 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Finalizes Technology Transfer of Manufacturing Process for Novel Gene Therapy

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has reached a significant milestone. The company successfully completed the technology transfer of its manufacturing process for the production of its lead candidate for immunogene therapy, REQORSA(TM). The transfer was made from the major cancer research institution where it had previously been manufactured to experienced, commercial contract development and manufacturing organizations (“CDMOs”). This step marks the first time REQORSA has been manufactured outside of the research institution where it was discovered and at commercial scale in a current Good Manufacturing Practices (“cGMP”)-compliant…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered